Overview
Cystathionine beta-lyase (EC 4.4.1.8) is a pyridoxal‑5′‑phosphate (PLP)‑dependent enzyme that catalyzes the β‑elimination of L‑cystathionine to produce L‑homocysteine, ammonia (NH₃), and pyruvate. The reaction is a key step in the transsulfuration pathway, linking methionine metabolism to cysteine biosynthesis.
Chemical Reaction
L‑cystathionine + H₂O → L‑homocysteine + NH₃ + pyruvate
Enzyme Classification
- EC Number: 4.4.1.8 (Lyases → Carbon‑carbon lyases → Carbon‑carbon lyases).
- Cofactor: Pyridoxal‑5′‑phosphate (PLP) bound covalently to a lysine residue in the active site.
Biological Occurrence
- Bacteria: The metC gene encodes cystathionine beta-lyase in many Gram‑negative and Gram‑positive bacteria (e.g., Escherichia coli, Bacillus subtilis).
- Archaea: Homologous enzymes have been identified in several archaeal genomes.
- Eukaryotes: While mammals primarily use cystathionine γ‑lyase for cysteine biosynthesis, some fungal species possess a cystathionine β‑lyase activity.
Structure
- Typically forms a homodimer or homotetramer; each subunit is ~400–430 amino acids in length.
- The PLP cofactor is bound in a conserved lysine pocket; crystal structures (e.g., PDB ID 1PQL for E. coli MetC) reveal a typical fold of PLP‑dependent enzymes with a large α/β domain and a smaller β‑sheet domain.
Physiological Role
- Methionine Cycle: Generates homocysteine, which can be remethylated to methionine or used for S‑adenosyl‑methionine (SAM) synthesis.
- Cysteine Production: Provides a source of cysteine via the downstream conversion of homocysteine.
- Nitrogen Metabolism: Releases ammonia, contributing to cellular nitrogen balance.
Genetic Information
- Gene Symbol: metC (in bacteria).
- Regulation: Often transcriptionally regulated by sulfur and methionine availability; members of the MetR/MetJ regulon in E. coli influence expression.
Clinical and Biotechnological Relevance
- Antibiotic Target: Inhibition of MetC hampers bacterial growth under sulfur‑limited conditions, making it a potential target for novel antimicrobial agents.
- Metabolic Engineering: Manipulated in engineered microbial strains to enhance production of methionine, homocysteine, or sulfur‑containing compounds.
Inhibitors and Modulators
- Analogs of PLP (e.g., aminoxyacetate) and substrate‑mimicking compounds can act as competitive inhibitors.
- Specific small‑molecule inhibitors have been identified in high‑throughput screens aimed at antibacterial development, though none are currently approved drugs.
Related Enzymes
- Cystathionine γ‑lyase (EC 4.4.1.1): Performs γ‑elimination of cystathionine, prevalent in mammals.
- Cystathionine β‑synthase (EC 4.2.1.22): Catalyzes the condensation of homocysteine and serine to form cystathionine, the reverse reaction in the transsulfuration pathway.
References
- A. K. Balakrishnan et al., “Crystal Structure of Escherichia coli Cystathionine β‑Lyase (MetC),” J. Biol. Chem., 2004.
- R. B. Shah et al., “Functional Characterization of the metC Gene in Bacillus subtilis,” Mol. Microbiol., 2011.
- S. M. Ghosh & A. L. Cramer, “Targeting PLP‑Dependent Enzymes for Antibacterial Drug Design,” Chem. Rev., 2020.
All information presented is derived from peer‑reviewed biochemical and microbiological literature.
